Cargando…
Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios
The emergence and fast global spread of COVID-19 has presented one of the greatest public health challenges in modern times with no proven cure or vaccine. Africa is still early in this epidemic, therefore the extent of disease severity is not yet clear. We used a mathematical model to fit to the ob...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380646/ https://www.ncbi.nlm.nih.gov/pubmed/32706790 http://dx.doi.org/10.1371/journal.pone.0236003 |
_version_ | 1783562891072372736 |
---|---|
author | Mukandavire, Zindoga Nyabadza, Farai Malunguza, Noble J. Cuadros, Diego F. Shiri, Tinevimbo Musuka, Godfrey |
author_facet | Mukandavire, Zindoga Nyabadza, Farai Malunguza, Noble J. Cuadros, Diego F. Shiri, Tinevimbo Musuka, Godfrey |
author_sort | Mukandavire, Zindoga |
collection | PubMed |
description | The emergence and fast global spread of COVID-19 has presented one of the greatest public health challenges in modern times with no proven cure or vaccine. Africa is still early in this epidemic, therefore the extent of disease severity is not yet clear. We used a mathematical model to fit to the observed cases of COVID-19 in South Africa to estimate the basic reproductive number and critical vaccination coverage to control the disease for different hypothetical vaccine efficacy scenarios. We also estimated the percentage reduction in effective contacts due to the social distancing measures implemented. Early model estimates show that COVID-19 outbreak in South Africa had a basic reproductive number of 2.95 (95% credible interval [CrI] 2.83–3.33). A vaccine with 70% efficacy had the capacity to contain COVID-19 outbreak but at very higher vaccination coverage 94.44% (95% Crl 92.44–99.92%) with a vaccine of 100% efficacy requiring 66.10% (95% Crl 64.72–69.95%) coverage. Social distancing measures put in place have so far reduced the number of social contacts by 80.31% (95% Crl 79.76–80.85%). These findings suggest that a highly efficacious vaccine would have been required to contain COVID-19 in South Africa. Therefore, the current social distancing measures to reduce contacts will remain key in controlling the infection in the absence of vaccines and other therapeutics. |
format | Online Article Text |
id | pubmed-7380646 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-73806462020-07-27 Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios Mukandavire, Zindoga Nyabadza, Farai Malunguza, Noble J. Cuadros, Diego F. Shiri, Tinevimbo Musuka, Godfrey PLoS One Research Article The emergence and fast global spread of COVID-19 has presented one of the greatest public health challenges in modern times with no proven cure or vaccine. Africa is still early in this epidemic, therefore the extent of disease severity is not yet clear. We used a mathematical model to fit to the observed cases of COVID-19 in South Africa to estimate the basic reproductive number and critical vaccination coverage to control the disease for different hypothetical vaccine efficacy scenarios. We also estimated the percentage reduction in effective contacts due to the social distancing measures implemented. Early model estimates show that COVID-19 outbreak in South Africa had a basic reproductive number of 2.95 (95% credible interval [CrI] 2.83–3.33). A vaccine with 70% efficacy had the capacity to contain COVID-19 outbreak but at very higher vaccination coverage 94.44% (95% Crl 92.44–99.92%) with a vaccine of 100% efficacy requiring 66.10% (95% Crl 64.72–69.95%) coverage. Social distancing measures put in place have so far reduced the number of social contacts by 80.31% (95% Crl 79.76–80.85%). These findings suggest that a highly efficacious vaccine would have been required to contain COVID-19 in South Africa. Therefore, the current social distancing measures to reduce contacts will remain key in controlling the infection in the absence of vaccines and other therapeutics. Public Library of Science 2020-07-24 /pmc/articles/PMC7380646/ /pubmed/32706790 http://dx.doi.org/10.1371/journal.pone.0236003 Text en © 2020 Mukandavire et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Mukandavire, Zindoga Nyabadza, Farai Malunguza, Noble J. Cuadros, Diego F. Shiri, Tinevimbo Musuka, Godfrey Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios |
title | Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios |
title_full | Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios |
title_fullStr | Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios |
title_full_unstemmed | Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios |
title_short | Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios |
title_sort | quantifying early covid-19 outbreak transmission in south africa and exploring vaccine efficacy scenarios |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380646/ https://www.ncbi.nlm.nih.gov/pubmed/32706790 http://dx.doi.org/10.1371/journal.pone.0236003 |
work_keys_str_mv | AT mukandavirezindoga quantifyingearlycovid19outbreaktransmissioninsouthafricaandexploringvaccineefficacyscenarios AT nyabadzafarai quantifyingearlycovid19outbreaktransmissioninsouthafricaandexploringvaccineefficacyscenarios AT malunguzanoblej quantifyingearlycovid19outbreaktransmissioninsouthafricaandexploringvaccineefficacyscenarios AT cuadrosdiegof quantifyingearlycovid19outbreaktransmissioninsouthafricaandexploringvaccineefficacyscenarios AT shiritinevimbo quantifyingearlycovid19outbreaktransmissioninsouthafricaandexploringvaccineefficacyscenarios AT musukagodfrey quantifyingearlycovid19outbreaktransmissioninsouthafricaandexploringvaccineefficacyscenarios |